On the way from DNA to product translation is a major bottleneck which may limit the specific productivity of mammalian production cell lines.
In the process of splicing a gene into a production cell, a new organism is created.
Every production cell, as the smallest shop-floor unit is called, starts the day with one.
Bright spots within each production cell are flow stagnation points.
Chinese hamster ovary (CHO) cells represent the most commonly used production cell line for therapeutic proteins.
Supplementation with serine, cysteine, and tyrosine enhanced mAb production, cell viability, and metabolic profiles.
First, a new sand production cell was designed and developed to study the sand production process.
The approach is illustrated using an example of a manufacturing production cell.
Production cell lines for biopharmaceuticals are created by stable genomic integration of expression constructs encoding the genes of interest.
The translation is illustrated using the TASM toolset in conjunction with the "production cell system" case study.
At different agitation speeds (200 500 rpm), changes of CHA production, cell mass, pH, and residual glucose were observed (Fig. 5a c).
